Literature DB >> 9231780

1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.

X Y Zhao1, L H Ly, D M Peehl, D Feldman.   

Abstract

We and others have recently shown that 1alpha,25-dihydroxyvitamin D3 [1,25-(OH)2D3] significantly inhibits cell proliferation and increases secretion of prostate-specific antigen (PSA) in LNCaP cells, an androgen-responsive human prostate cancer cell line. The present study was designed to investigate the possible interactions between 1,25-(OH)2D3 and androgens in the regulation of LNCaP cellular function. LNCaP cell growth was dose-dependently inhibited by 1,25-(OH)2D3 (60% inhibition at 10 nM) when cells were cultured in medium supplemented with FBS (FBS medium). 1,25-(OH)2D3-treated cells showed a 5-fold increase in PSA secretion, similar to the increase seen in dihydrotestosterone (DHT)-treated cells. In combination, 1,25-(OH)2D3 and DHT synergistically enhanced PSA secretion 22-fold. This synergistic effect was even greater when cells were cultured in medium supplemented with charcoal-stripped serum (CSS medium), where endogenous steroids are substantially depleted. Under these conditions, 1,25-(OH)2D3 and DHT together stimulated PSA secretion up to 50-fold over the untreated control. Radioligand binding assays and Western blot analyses showed that the androgen receptor (AR) content was increased significantly by 1,25-(OH)2D3 at 48 h. Furthermore, the steady-state mRNA level of AR was up-regulated approximately 2-fold by 1,25-(OH)2D3 at 24 h. When cells were grown in CSS medium, 1,25-(OH)2D3 alone no longer inhibited cell growth or induced PSA secretion. Titration experiments revealed that the addition of DHT at 1 nM to the medium restored the antiproliferative activity of 1,25-(OH)2D3. Conversely, an antiandrogen, Casodex, completely blocked 1,25-(OH)2D3 antiproliferative and PSA stimulation activities when cells were cultured in FBS medium. In conclusion, these results demonstrate that the antiproliferative and PSA induction activities of 1,25-(OH)2D3 in LNCaP cells are dependent upon androgen action and that AR up-regulation by 1,25-(OH)2D3 likely contributes to the synergistic actions of 1,25-(OH)2D3 and DHT in these cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9231780     DOI: 10.1210/endo.138.8.5328

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  18 in total

Review 1.  New trial designs to assess antitumor and antiproliferative agents in prostate cancer.

Authors:  Walter Stadler
Journal:  Invest New Drugs       Date:  2002-05       Impact factor: 3.850

2.  Dietary vitamin D and vitamin D receptor level modulate epithelial cell proliferation and apoptosis in the prostate.

Authors:  Pavlo L Kovalenko; Zhentao Zhang; Jun-Ge Yu; Yan Li; Steven K Clinton; James C Fleet
Journal:  Cancer Prev Res (Phila)       Date:  2011-08-11

3.  Associations Between Serum Vitamin D and Adverse Pathology in Men Undergoing Radical Prostatectomy.

Authors:  Yaw A Nyame; Adam B Murphy; Diana K Bowen; Gregory Jordan; Ken Batai; Michael Dixon; Courtney M P Hollowell; Stephanie Kielb; Joshua J Meeks; Peter H Gann; Virgilia Macias; Andre Kajdacsy-Balla; William J Catalona; Rick Kittles
Journal:  J Clin Oncol       Date:  2016-02-22       Impact factor: 44.544

4.  1{alpha},25-Dihydroxyvitamin D3 inhibits growth of VCaP prostate cancer cells despite inducing the growth-promoting TMPRSS2:ERG gene fusion.

Authors:  Michele N Washington; Nancy L Weigel
Journal:  Endocrinology       Date:  2010-02-10       Impact factor: 4.736

5.  Interleukin-1α mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cells.

Authors:  Sophia L Maund; Wendy W Barclay; Laura D Hover; Linara S Axanova; Guangchao Sui; Jason D Hipp; James C Fleet; Andrew Thorburn; Scott D Cramer
Journal:  Cancer Res       Date:  2011-06-08       Impact factor: 12.701

6.  GADD45gamma: a new vitamin D-regulated gene that is antiproliferative in prostate cancer cells.

Authors:  Omar Flores; Kerry L Burnstein
Journal:  Endocrinology       Date:  2010-08-25       Impact factor: 4.736

7.  Androgen Receptor regulation of Vitamin D receptor in response of castration-resistant prostate cancer cells to 1α-Hydroxyvitamin D5 - a calcitriol analog.

Authors:  Benjamin Mooso; Anisha Madhav; Sherra Johnson; Mohana Roy; Mary E Moore; Christabel Moy; Grace A Loredo; Rajendra G Mehta; Andrew T M Vaughan; Paramita M Ghosh
Journal:  Genes Cancer       Date:  2010-11-16

Review 8.  (Patho)physiological implications of the novel epithelial Ca2+ channels TRPV5 and TRPV6.

Authors:  Tom Nijenhuis; Joost G J Hoenderop; Bernd Nilius; René J M Bindels
Journal:  Pflugers Arch       Date:  2003-05-13       Impact factor: 3.657

9.  Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor.

Authors:  Mee Young Hong; Navindra P Seeram; David Heber
Journal:  J Nutr Biochem       Date:  2008-05-13       Impact factor: 6.048

10.  Calcitriol and TO-901317 interact in human prostate cancer LNCaP cells.

Authors:  Jing-Huan Wang; Pentti Tuohimaa
Journal:  Gene Regul Syst Bio       Date:  2008-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.